Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 5, 2015, Pages 2898-2900

  Cannatelli, Antonio ^a   Santos Lopez, Alfonso ^b   Giani, Tommaso ^a   Gonzalez Zorn, Bruno ^b   Rossolini, Gian Maria ^a,c,d  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF FLORENCE   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

POLYMYXIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; CELL LINEAGE; GENE; GENE FUNCTION; GENE INACTIVATION; GENE INSERTION SEQUENCE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC STABILITY; IN VITRO STUDY; INVESTIGATIVE PROCEDURES; KLEBSIELLA PNEUMONIAE; MGRB GENE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE; DRUG EFFECTS; GENETICS; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMYXINS;

EID: 84931281649     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04998-14     Document Type: Article

References (20)

1. Rossolini GM, Arena F, Pecile P, Pollini S. 2014. Update on the antibiotic resistance crisis. Curr Opin Pharmacol 18C:56-60. http://dx.doi.org/10.1016/j.coph.2014.09.006.
2. Falagas ME, Kasiakou SK. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 40:1333-1341. http://dx.doi.org/10.1086/429323.
3. Petrosillo N, Giannella M, Lewis R, Viale P. 2013. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther 11:159-177. http://dx.doi.org/10.1586/eri.12.162.
4. Cai Y, Chai D, Wang R, Liang B, Bai N. 2012. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 67:1607-1615. http://dx.doi.org/10.1093/jac/dks084.
5. Kim Y, Bae IK, Lee H, Jeong SH, Yong D, Lee K. 2014. In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment. Diagn Microbiol Infect Dis 79:362-366. http://dx.doi.org/10.1016/j.diagmicrobio.2014.03.027.
6. Ah YM, Kim AJ, Lee JY. 2014. Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents 44:8-15. http://dx.doi.org/10.1016/j.ijantimicag.2014.02.016.
7. Pena I, Picazo JJ, Rodríguez-Avial C, Rodríguez-Avial I. 2014. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int J Antimicrob Agents 43:460-464. http://dx.doi.org/10.1016/j.ijantimicag.2014.01.021.
8. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, Network EuSCAPE-Italy, Grundmann H, Pantosti A, Rossolini GM. 2014. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 19:piiô20939. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20939.
9. Beceiro A, Moreno A, Fernández N, Vallejo JA, Aranda J, Adler B, Harper M, Boyce JD, Bou G. 2014. Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob Agents Chemother 58:518-526. http://dx.doi.org/10.1128/AAC.01597-13.
10. López-Rojas R, McConnell MJ, Jiménez-Mejías ME, Domínguez-Herrera J, Fernández-Cuenca F, Pachón J. 2013. Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness. Antimicrob Agents Chemother 57:4587-4589. http://dx.doi.org/10.1128/AAC.00543-13.
11. Cannatelli A, D'Andrea MM, Giani T, Di Pilato V, Arena F, Ambretti S, Gaibani P, Rossolini GM. 2013. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 57:5521-5526. http://dx.doi.org/10.1128/AAC.01480-13.
12. Lippa AM, Goulian M. 2009. Feedback inhibition in the PhoQ/PhoP signaling system by a membrane peptide. PLoS Genet 5:e1000788. http://dx.doi.org/10.1371/journal.pgen.1000788.
13. Cheng HY, Chen YF, Peng H-L. 2010. Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43. J Biomed Sci 17:60-76. http://dx.doi.org/10.1186/1423-0127-17-60.
14. Cannatelli A, Giani T, D'Andrea MM, Di Pilato V, Arena F, Conte V, Tryfinopoulou K, Vatopoulos A, Rossolini GM, COLGRIT Study Group. 2014. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 58:5696-5703. http://dx.doi.org/10.1128/AAC.03110-14.
15. Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Türkoglu S, Nordmann P. 2014. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 70:75-80. http://dx.doi.org/10.1093/jac/dku323.
16. Olaitan AO, Diene SM, Kempf M, Berrazeg M, Bakour S, Gupta SK, Thongmalayvong B, Akkhavong K, Somphavong S, Paboriboune P, Chaisiri K, Komalamisra C, Adelowo OO, Fagade OE, Banjo OA, Oke AJ, Adler A, Assous MV, Morand S, Raoult D, Rolain JM. 2014. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents 44:500-507. http://dx.doi.org/10.1016/j.ijantimicag.2014.07.020.
17. th ed. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Gutierrez B, Escudero JA, San Millan A, Hidalgo L, Carrilero L, Ovejero CM, Santos-Lopez A, Thomas-Lopez D, Gonzalez-Zorn B. 2012. Fitness cost and interference of Arm/Rmt aminoglycoside resistance with the RsmF housekeeping methyltransferases. Antimicrob Agents Chemother 56:2335-2341. http://dx.doi.org/10.1128/AAC.06066-11.
19. Cannatelli A, Di Pilato V, Giani T, Arena F, Ambretti S, Gaibani P, D'Andrea MM, Rossolini GM. 2014. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC carbapenemase-producing Klebsiella pneumoniae associated with low-dosage colistin treatment. Antimicrob Agents Chemother 58:4399-4403. http://dx.doi.org/10.1128/AAC.02555-14.
20. Giani T, Conte V, Mandalà S, D'Andrea MM, Luzzaro F, Conaldi Grossi P, Rossolini GM. 2014. Cross-infection of solid organ transplant recipients by a multidrug-resistant Klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor. J Clin Microbiol 52:2702-2705. http://dx.doi.org/10.1128/JCM.00511-14.